Medicare Coverage Appeals Regulation Remains Distant Goal For CMS
This article was originally published in The Gray Sheet
Executive Summary
Establishing an appeals process for local and national coverage decisions has been relegated to CMS' list of "long-term" goals, according to the 1HHS semiannual regulatory plan, released Dec. 3
You may also be interested in...
Clinical Trials Need Peer Review To Qualify For Medicare Funds - AHRQ Panel
Clinical trials seeking Medicare reimbursement of routine care costs should first undergo an external scientific review, according to a multi-agency panel convened by the Agency for Healthcare Research & Quality.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.